110 related articles for article (PubMed ID: 18436711)
21. Mkk4 and Mkk7 are important for retinal development and axonal injury-induced retinal ganglion cell death.
Syc-Mazurek SB; Rausch RL; Fernandes KA; Wilson MP; Libby RT
Cell Death Dis; 2018 Oct; 9(11):1095. PubMed ID: 30367030
[TBL] [Abstract][Full Text] [Related]
22. Mitogen Kinase Kinase (MKK7) Controls Cytokine Production In Vitro and In Vivo in Mice.
Caliz AD; Yoo HJ; Vertii A; Dolan AC; Tournier C; Davis RJ; Keaney JF; Kant S
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502275
[TBL] [Abstract][Full Text] [Related]
23. Differential activation of two JNK activators, MKK7 and SEK1, by MKN28-derived nonreceptor serine/threonine kinase/mixed lineage kinase 2.
Hirai S; Noda K; Moriguchi T; Nishida E; Yamashita A; Deyama T; Fukuyama K; Ohno S
J Biol Chem; 1998 Mar; 273(13):7406-12. PubMed ID: 9516438
[TBL] [Abstract][Full Text] [Related]
24. Synoviocyte innate immune responses: I. Differential regulation of interferon responses and the JNK pathway by MAPK kinases.
Yoshizawa T; Hammaker D; Sweeney SE; Boyle DL; Firestein GS
J Immunol; 2008 Sep; 181(5):3252-8. PubMed ID: 18713996
[TBL] [Abstract][Full Text] [Related]
25. Activation of the c-Jun NH
Fung TS; Liu DX
Cell Death Dis; 2017 Dec; 8(12):3215. PubMed ID: 29238080
[TBL] [Abstract][Full Text] [Related]
26. Distinct signaling properties of mitogen-activated protein kinase kinases 4 (MKK4) and 7 (MKK7) in embryonic stem cell (ESC) differentiation.
Wang J; Chen L; Ko CI; Zhang L; Puga A; Xia Y
J Biol Chem; 2012 Jan; 287(4):2787-97. PubMed ID: 22130668
[TBL] [Abstract][Full Text] [Related]
27. Antitumor effect of the angiogenesis inhibitor bevacizumab is dependent on susceptibility of tumors to hypoxia-induced apoptosis.
Selvakumaran M; Yao KS; Feldman MD; O'Dwyer PJ
Biochem Pharmacol; 2008 Feb; 75(3):627-38. PubMed ID: 18178171
[TBL] [Abstract][Full Text] [Related]
28. Requirements for PKC-augmented JNK activation by MKK4/7.
Lopez-Bergami P; Ronai Z
Int J Biochem Cell Biol; 2008; 40(5):1055-64. PubMed ID: 18182317
[TBL] [Abstract][Full Text] [Related]
29. Stress-activated protein kinase MKK7 regulates axon elongation in the developing cerebral cortex.
Yamasaki T; Kawasaki H; Arakawa S; Shimizu K; Shimizu S; Reiner O; Okano H; Nishina S; Azuma N; Penninger JM; Katada T; Nishina H
J Neurosci; 2011 Nov; 31(46):16872-83. PubMed ID: 22090513
[TBL] [Abstract][Full Text] [Related]
30. The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras.
Byun JY; Yoon CH; An S; Park IC; Kang CM; Kim MJ; Lee SJ
Carcinogenesis; 2009 Nov; 30(11):1880-8. PubMed ID: 19783847
[TBL] [Abstract][Full Text] [Related]
31. Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBPbeta-dependent pathway.
Healy ZR; Zhu F; Stull JD; Konstantopoulos K
Am J Physiol Cell Physiol; 2008 May; 294(5):C1146-57. PubMed ID: 18367585
[TBL] [Abstract][Full Text] [Related]
32. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
33. Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity.
Cooper SL; Sandhu H; Hussain A; Mee C; Maddock H
Toxicology; 2018 Feb; 394():72-83. PubMed ID: 29248607
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor receptor 1/c-Jun-NH2-kinase signaling promotes human neoplasia.
Zhang JY; Adams AE; Ridky TW; Tao S; Khavari PA
Cancer Res; 2007 Apr; 67(8):3827-34. PubMed ID: 17440097
[TBL] [Abstract][Full Text] [Related]
35. Widespread JNK-dependent alternative splicing induces a positive feedback loop through CELF2-mediated regulation of MKK7 during T-cell activation.
Martinez NM; Agosto L; Qiu J; Mallory MJ; Gazzara MR; Barash Y; Fu XD; Lynch KW
Genes Dev; 2015 Oct; 29(19):2054-66. PubMed ID: 26443849
[TBL] [Abstract][Full Text] [Related]
36. Neddylation controls basal MKK7 kinase activity in breast cancer cells.
Zhu T; Wang J; Pei Y; Wang Q; Wu Y; Qiu G; Zhang D; Lv M; Li W; Zhang J
Oncogene; 2016 May; 35(20):2624-33. PubMed ID: 26364603
[TBL] [Abstract][Full Text] [Related]
37. Age-dependent motor dysfunction due to neuron-specific disruption of stress-activated protein kinase MKK7.
Yamasaki T; Deki-Arima N; Kaneko A; Miyamura N; Iwatsuki M; Matsuoka M; Fujimori-Tonou N; Okamoto-Uchida Y; Hirayama J; Marth JD; Yamanashi Y; Kawasaki H; Yamanaka K; Penninger JM; Shibata S; Nishina H
Sci Rep; 2017 Aug; 7(1):7348. PubMed ID: 28779160
[TBL] [Abstract][Full Text] [Related]
38. MKK7 transcription positively or negatively regulated by SP1 and KLF5 depends on HDAC4 activity in glioma.
Wang Y; Xia Y; Hu K; Zeng M; Zhi C; Lai M; Wu L; Liu S; Zeng S; Huang Z; Ma S; Yuan Z
Int J Cancer; 2019 Nov; 145(9):2496-2508. PubMed ID: 30963560
[TBL] [Abstract][Full Text] [Related]
39. The Neuregulin-Rac-MKK7 pathway regulates antagonistic c-jun/Krox20 expression in Schwann cell dedifferentiation.
Shin YK; Jang SY; Park JY; Park SY; Lee HJ; Suh DJ; Park HT
Glia; 2013 Jun; 61(6):892-904. PubMed ID: 23505039
[TBL] [Abstract][Full Text] [Related]
40. The CXCR2 antagonist, SCH-527123, shows antitumor activity and sensitizes cells to oxaliplatin in preclinical colon cancer models.
Ning Y; Labonte MJ; Zhang W; Bohanes PO; Gerger A; Yang D; Benhaim L; Paez D; Rosenberg DO; Nagulapalli Venkata KC; Louie SG; Petasis NA; Ladner RD; Lenz HJ
Mol Cancer Ther; 2012 Jun; 11(6):1353-64. PubMed ID: 22391039
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
